Stay Connected

Sign Up for Updates

We are creating a place where we can share ideas, provide the perspective of America's biopharmaceutical companies and, most importantly, listen to you.

Medicare Part D Continues to Hold Down Costs, Maintain High Level of Patient Satisfaction

By Allyson Funk  |    August 28, 2014
Yesterday, the latest Congressional Budget Office (CBO) report was released examining projected long-term federal spending, including that of Medicare. Estimated Medicare spending will be...   Read More

ICYMI: Coverage of expensive drugs tops patients’ concerns

By Allyson Funk  |    August 18, 2014
A new story from the AP today, “Patient advocates say insurers avoiding the sick,” highlights the growing concern among patients and insurance commissioners about high cost-sharing for medicines in...   Read More

Second Annual PhRMA Survey: How Americans View Their Health, Three Important New Health Trends to Watch

By PhRMA Staff  |    August 13, 2014
This week we released From Hope to Cures: PhRMA’s Second Annual National Health Survey revealing new data on how Americans view their own health as well as that of the Nation. The survey also reveals...   Read More

Medicare Part D Continues to Be A Success

By Allyson Funk  |    August 4, 2014
Medicare Part D continues to be a success for beneficiaries. A new report released last week by the Congressional Budget Office (CBO), noted that Part D spending in 2013 was nearly 50 percent less...   Read More

Biopharmaceutical Research Companies Developing 92 Medicines to Treat Arthritis and Musculoskeletal Diseases

By Robert Zirkelbach  |    August 4, 2014
A Conversation on Continuing to Improve the Lives of Patients Living with Arthritis For many patients, hope for a brighter future is directly tied to the potential of medicines in the pipeline to...   Read More

Search the Catalyst

View Posts by Topic

see all

Subscribe to Email Updates